Range Low Price High Price Comment
30 days $27.00 $36.72 Thursday, 28th Mar 2024 ARWR stock ended at $28.60. This is 0.348% less than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 3.44% from a day low at $28.10 to a day high of $29.07.
90 days $27.00 $39.83
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2021-05-10 $65.95 $67.29 $64.42 $66.10 806 745
2021-05-07 $66.71 $67.50 $65.16 $66.38 623 371
2021-05-06 $65.50 $66.04 $61.91 $65.66 914 753
2021-05-05 $66.06 $68.65 $65.19 $66.47 923 060
2021-05-04 $68.04 $70.06 $66.13 $66.48 808 017
2021-05-03 $73.00 $73.98 $70.21 $70.24 559 253
2021-04-30 $75.00 $77.28 $71.97 $72.76 899 392
2021-04-29 $77.12 $77.12 $73.47 $75.76 607 358
2021-04-28 $74.53 $76.71 $74.52 $75.96 721 615
2021-04-27 $75.00 $75.41 $73.66 $74.52 663 489
2021-04-26 $72.00 $74.93 $71.59 $74.50 653 906
2021-04-23 $71.58 $72.35 $70.50 $71.59 558 985
2021-04-22 $69.60 $72.15 $68.42 $70.99 711 769
2021-04-21 $67.84 $69.24 $66.68 $69.03 554 573
2021-04-20 $66.91 $68.86 $65.43 $68.12 466 516
2021-04-19 $66.49 $68.45 $65.91 $67.00 537 964
2021-04-16 $68.49 $69.47 $67.23 $67.65 632 069
2021-04-15 $69.65 $69.70 $66.24 $67.98 720 699
2021-04-14 $64.57 $68.22 $64.45 $67.17 648 737
2021-04-13 $63.65 $64.70 $62.12 $63.93 406 897
2021-04-12 $62.01 $62.90 $60.52 $62.78 493 278
2021-04-09 $63.20 $63.25 $61.29 $62.15 783 255
2021-04-08 $64.96 $65.74 $63.40 $63.71 399 010
2021-04-07 $64.79 $65.45 $63.16 $63.39 517 427
2021-04-06 $66.00 $67.56 $65.03 $65.15 411 672
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT